Strona 7 - Najlepsi lekarze wykonujący podstawowe badanie kontrolne – TOP 261 lekarz

Edukacja i specjalizacja

• Wydział Lekarski Uniwersytetu Hacettepe – Edukacja Medyczna w Języku Angielskim
• Wydział Lekarski Uniwersytetu Akdeniz – Medycyna Wewnętrzna – Rezydentura
• Szpital Uniwersytecki Akdeniz – Nefrologia – Szkolenie w zakresie specjalizacji
• Szpital San Bortolo, Vicenza, Włochy – Nefrologia i Transplantologia Intensywna Terapia – Stypendium
• Wydział Lekarski Uniwersytetu Hacettepe – stanowisko profesora nadzwyczajnego

Członkostwa profesjonalne

1. Tureckie Towarzystwo Nefrologiczne (TND)
2. Europejskie Towarzystwo Nefrologiczne (ERA-EDTA)
3. Bliskowschodnie Towarzystwo Transplantacji Narządów (MESOT)
4. Międzynarodowe Towarzystwo Nefrologiczne (ISN)

Dr. Zhang Yan Lin is a nationally recognized nephrologist with over 30 years in clinical care, teaching, and research. Dr. Zhang previously worked at the First Affiliated Hospital of Xiamen University.

Dr. Zhang took part in two NSFC projects, served as principal investigator for one Fujian Provincial NSFC project, and led two Xiamen Municipal key projects. Dr. Zhang is chief editor of one monograph and co-editor of three. Dr. Zhang has published more than 30 papers, including six in SCI journals.

Appointments: Deputy Chair of the Immunoadsorption and Cell Therapy Group of the Internal Medicine Branch of the Chinese Medical Association. Deputy Chair of the Nephrology Branch of the Asia-Pacific Academy of Medical and Biological Immunology. Standing Committee Member of the Nephrology and Dialysis Professional Committee of the China Non-Public Medical Institutions Association. Standing Committee Member of the East China Regional Nephrology Cooperation Committee.

Dr Tian Jian Qing is Director of Endocrinology and a Senior Expert in Endocrine & Metabolic Therapeutics. He has over 20 years of clinical experience. He previously worked at Xinjiang Military Command General Hospital and at Renji Hospital, Shanghai Jiao Tong University.

He has published over 20 SCI and Chinese core journal papers. He is chief editor of four monographs and co-editor of four others. He has produced more than 1,000 health education materials. His clinical focus includes endocrine and metabolic disorders, dysglycemia, dyslipidemia, and hypertension. He also treats weight, thyroid, and bone diseases, menopausal syndrome, PCOS, and gestational diabetes and thyroid disorders.

He holds Standing Council and Committee roles in the Fujian Cross-Strait Medicine & Health Exchange Association and the Fujian Primary Health Association. He also serves in the Xiamen Medical Association and the Xiamen Medical Doctor Association. He is Deputy Chair of the Diabetes Branch of the Xiamen Medical Association.

edukacja

• 2002 - 2008, Uniwersytet w Ege, studia licencjackie, lekarz medycyny
• 2009 - 2013, Szpital Szkoleniowo-Badawczy Bagcilar w Stambule, specjalizacja z kardiologii
• 2013 - 2018, Uniwersytet Bezm-i Alem Vakif, adiunkt
• 2018 – 2021, Uniwersytet Bezm-i Alem Vakif, profesor nadzwyczajny

Doświadczenie

• 2009 - 2013, Szpital Szkoleniowo-Badawczy Bagcilar w Stambule
• 2013, Szpital Państwowy Esenler Basaksehir w Stambule
• 2014, Szpital Państwowy Bursa Mustafakemalpasa
• 2013 – 2014, Ministerstwo Zdrowia Szpital Mehmeta Akifa Ersoya
• 2014 – 2016, Szpital Państwowy Mustafakemalpasa, Bursa
• 2016 – 2024, Uniwersytet Bezm-i Alem Vakif
• 2024 – obecnie, Szpital Medipol Acibadem

Edukacja i doświadczenie

• 1992 - 1998, Uniwersytet Gaziantep, Wydział Lekarski
• 2002 – 2015, Uniwersytet Cumhuriyet, Wydział Lekarski, Katedra Chorób Wewnętrznych
• 2015 – 2024, Szpital Uniwersytecki Bağcılar Medipol Mega
• 2024 – obecnie, Szpital Medipol Acıbadem

Edukacja i wiedza specjalistyczna

UNIWERSYTET BAŞKENT, WYDZIAŁ MEDYCZNY

choroby

Niewydolność serca

Choroby zastawkowe

Otwory w sercu

Niedrożność układu sercowo-naczyniowego

Tętniak żyły aorty

Kardioonkologia

Nadciśnienie oporne

Zaburzenia rytmu

Metody leczenia

Zastosowania rozruszników serca

Mitraclip

triclip

Aplikacja TAVI

Zamykanie dziur w sercu

Stent balonowy

Zastosowanie stentu w tętniakach aorty

Badania serca u pacjentów onkologicznych

U pacjentów z nadciśnieniem opornym

Zastosowanie ablacji Denewacja nerek

Zastosowanie krioterapii

Doświadczenie

2005 – 2010 Uniwersytet Başkent Wydział Lekarski – Specjalizacja

2010 – Szkolenie z zakresu kardiologii interwencyjnej w Cleveland Clinic

Członkostwo profesjonalne

Tureckie Towarzystwo Kardiologiczne

Tureckie Stowarzyszenie Medyczne

Europejskie Towarzystwo Kardiologiczne (ESC)

Europejskie Stowarzyszenie Obrazowania Sercowo-Naczyniowego (EAVI)

Dr. Özcan Uzun is a nephrology specialist. He earned his medical degree from Atatürk University Faculty of Medicine (2005-2011). He completed his internal medicine and nephrology training at Dokuz Eylül University Faculty of Medicine (2012-2016, 2018-2022).

Dr. Uzun treats acute and chronic kidney failure, diabetic kidney disease, Fabry disease, glomerulonephritis, hyponatremia, kidney disease related to heart failure, and vasculitis. He is skilled in managing diabetic kidney disease, treating glomerulonephritis, providing hemodialysis, and controlling hypertension.

He has worked as an internal medicine specialist at Batman Training and Research Hospital. He also served as a nephrology specialist at Yalova State Hospital. Dr. Uzun is a member of the Turkish Nephrology Association and the Izmir Medical Chamber.

Dr. Ertuğrul Ercan is a Professor of Cardiology. He completed his training at Ege University and Çanakkale Onsekiz Mart University. His main areas of expertise are interventional cardiology, atherosclerosis, valve diseases, and coronary artery disease. He also focuses on inflammation and coagulation, cardiovascular immunology, and stem cell therapy.

Dr. Ercan has held key academic and administrative positions. He served as Head of Cardiology and Dean at Çanakkale Onsekiz Mart University. He was also the Medical Director at İzmir Medical Point Hospital. He gained international experience at the Cleveland Clinic and in Melbourne, Australia.

He holds the European Cardiologist Diploma and is a Fellow of the European Society of Cardiology. Dr. Ercan is also a member of several national and international cardiology associations and working groups.

Dr. Ornicha Thititagul (Dr. Faangkaow) is a geriatrician and lecturer in the Geriatric Medicine Division at Siriraj Hospital, Mahidol University. She practices at Siriraj Samut Sakhon Geriatric Healthcare Center and Siriraj Piyamaharajkarun Hospital.

Accreditations include: M.D. (Second Class Honors, 2017); Diplomate, Thai Board of Internal Medicine (2021); WHO‑SEARO ICOPE Master Trainer (2021). Additional credentials: Diplomate in Geriatric Medicine (2023); Diplomate, International Board of Lifestyle Medicine (2024).

Research highlights include: a randomized controlled trial on oral nutritional supplements in older adults (Geriatrics, 2024); PG‑SGA versus MNA in hepatocellular carcinoma (Support Care Cancer 33, 116, 2025); and Thailand’s first abacavir hypersensitivity case report (J Med Assoc Thai, 2021). She was on the host team and served as a moderator at the 10th Asian Conference of Frailty and Sarcopenia in 2024.

2002 – 2008 – Siriraj Medical School, Mahidol University

2008 – 2013 – Department of Internal Medicine, Rajavithi Hospital

2013 – 2015 – Department of Cardiology, Internal Medicine Rajavithi Hospital

2019 – 2020 – Cardiology Intervention, Department of Cardiology, Internal Medicine Rajavithi Hospital

Languages: English and Thai

Dr. Cagdas Erdogan is a gastroenterologist at Ankara Etlik City Hospital. He trained in Internal Medicine and Gastroenterology. He earned his MD from Dokuz Eylul University. He completed his Internal Medicine residency from 2014 to 2019. He then completed a Gastroenterology fellowship at Ankara City Hospital from 2019 to 2022. His clinical focus includes advanced endoscopy (ERCP, EUS, EMR, ESD, POEM, EGD, colonoscopy, double-balloon enteroscopy), inflammatory bowel disease, and hepatology.

He has about 40 publications. His work appears in The Turkish Journal of Gastroenterology, Scientific Reports, Endoscopy, and Digestive Diseases and Sciences. Notable studies address vedolizumab in IBD and prophylaxis for post-ERCP pancreatitis. He also reported a 13-year Crohn’s cohort comparing infliximab and adalimumab. Additional work covers outcomes with an adalimumab biosimilar and innovative endoscopic therapies (MCA via double-balloon enteroscopy, holmium laser for Bouveret syndrome, POEM for Zenker’s diverticulum, and ESD for esophageal papillomatosis).

Dr. Zuhal Cakmak Peksen is a Family Medicine Specialist since 2017. She earned her MD from Çukurova University in 2010. She completed specialty training at Yüzüncü Yıl University between 2013 and 2017. She is currently studying for a bachelor’s degree in Health Management at Anadolu University (2024–present).

She has 15 years of clinical practice (2010–2025) across 8 institutions. Her experience includes research in Family Medicine (2013–2017) and work at several Family Health Centers. Since 2020, she has served at TOKİ Avrupa Family Health Center in Gaziosmanpaşa, Istanbul.

Dr. Humayun Kakar is a cardiologist. He earned his medical degree from Eskişehir Osmangazi University between 2007 and 2014. He completed his cardiology residency at İzmir Dokuz Eylül University from 2015 to 2020. In 2024, he received advanced training in heart failure at the University of Zurich in Switzerland.

He has worked at İzmir Ekonomi Üniversitesi Medical Point Hospital and Konya Cihanbeyli State Hospital. He also took part in advanced heart failure education at the University of Zurich.

Dr. Kakar is a member of several professional organizations. These include the European Society of Cardiology, Turkish Society of Cardiology, Heart Failure Association, American College of Cardiology, Cardiovascular Academy Association, and the European Association of Percutaneous Cardiovascular Interventions (EAPCI).

Dr. Mustafa Dogdus is a cardiologist who graduated from Ege University Faculty of Medicine. He has broad experience in treating complex heart conditions. His expertise includes arrhythmias, atrial septal defect (ASD), atrial fibrillation, AVRT, AVNRT, bradycardia, heart failure, coronary artery disease, and structural heart diseases.

He is skilled in advanced interventional procedures. These include ASD, PDA, and VSD closure, EPS-ablation, ICD-CRT-D implantation, and percutaneous coronary and peripheral interventions. Dr. Dogdus worked at Karaman State Hospital and Uşak University Training and Research Hospital cardiology clinics from 2017 to 2022.

He is an active member of the Turkish Society of Cardiology, the European Society of Cardiology, and the Cardiovascular Academy. He also holds board and working group positions in several national and international cardiology organizations.

Wissarut Sakulpaptong, M.D., is a board-certified cardiologist and a cardiology staff member at King Chulalongkorn Memorial Hospital. He specializes in advanced echocardiography. His work includes transthoracic and transesophageal studies, strain analysis, 3D and stress echocardiography, and imaging for congenital heart disease. He also holds an M.Sc. (Medicine) from Chulalongkorn University.

His leadership roles include Chief Fellow (2024) and Chief Resident (2022). His awards include Second Prize at the 2025 Echocardiography Annual Scientific Meeting (Heart Association of Thailand), 2021 Outstanding Second-Year Resident, and 2017 Outstanding Medical Graduate. He developed an NSTEMI care pathway, a Screening Echocardiogram Project, and a Home-Visit Warfarin Clinic. He presented research on sepsis-induced myocardial dysfunction. He also contributed to Thailand’s 2022 migraine guideline.

Dr. Boaz Liberman, MD, is an orthopedic oncologist and sarcoma surgeon for adults and children. He directs the Orthopedic Oncology Unit and serves as Vice Head of Orthopedic Surgery at Sheba Medical Center. His focus is limb-sparing cancer surgery with functional reconstruction. He performs complex joint reconstruction, revision arthroplasty, MRgFUS, and reconstruction after bone metastases.

Education and training: MD, Tel Aviv University. Orthopedic surgery residency, Sheba Medical Center. Fellowships in Adult Reconstruction at Mount Sinai Hospital, Toronto, and in Orthopedic Oncology at Mount Sinai Hospital and Princess Margaret Cancer Centre. He is board-certified in Orthopedic Surgery and in Orthopedic Oncology Surgery. He is a Clinical Instructor at Tel Aviv University. Memberships include the Israel Medical Association, Israel Orthopedic Association, AATB, and EATB. He also serves on national advisory committees. His research covers bone and soft tissue sarcomas, serum markers, imaging-guided therapies, MRI arthrography, and the biomechanics of bone treated with MRgFUS.

Dr. David (Dudi) Mishali, MD, is Director of Pediatric and Congenital Cardiothoracic Surgery at Sheba Medical Center. He treats infants and children with congenital heart defects. His work includes rare, high-risk anomalies and complex newborn reconstructions.

He trained internationally. He completed his residency at Rabin Medical Center and clinical fellowships in cardiac surgery at the Cleveland Clinic and in congenital pediatric cardiothoracic surgery at UCSF. He is board certified in cardiothoracic surgery. He developed and implemented minimally invasive methods that reduce surgical trauma and improve cosmetic results.

He is a Senior Lecturer at Tel Aviv University’s Sackler Faculty of Medicine. He has written many peer-reviewed papers and book chapters, including on point-of-care testing in children during cardiopulmonary bypass and on accessory mitral valve tissue. He holds a leadership role at a hospital ranked among the world’s top 10.

Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.

He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.

He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.

Doświadczenie

2019-2022

Uniwersytet Nauk o Zdrowiu, Wydział Lekarski, Szpital Miejski w Ankarze, Klinika Kardiologii, Ankara

2017-2019

Uniwersytet Nauk o Zdrowiu, Wydział Lekarski, Turcja Szpital Kształcenia i Badań Specjalistycznych, Klinika Kardiologii, Ankara,

2012-2017

Szpital Kształcenia i Badań Wyższej Specjalizacji w Turcji, Klinika Kardiologii, Ankara,

2012-2017

Uniwersytet TR Karabük, Wydział Lekarski, Katedra Kardiologii

2006 - 2006

Szpital Kształcenia i Badań Wyższej Specjalizacji w Turcji, Klinika Kardiologii, Ankara,

2001 - 2006

Szpital Kształcenia i Badań Wyższej Specjalizacji w Turcji, Klinika Kardiologii, Ankara,

1996 - 2001

Szpital Kształcenia i Badań Wyższej Specjalizacji w Turcji, Klinika Kardiologii, Ankara,

Edukacja

2017 Uniwersytet Karabük, Wydział Lekarski, Katedra Kardiologii

2006 Szpital Kształcenia i Badań Wyższej Specjalizacji w Turcji, Klinika Kardiologii

2001 Szpital Kształcenia i Badań Wyższej Specjalizacji w Turcji, Ankara, Kardiologia

1996 Uniwersytet w Ankarze, Wydział Lekarski

Doświadczenie:

2023 -

Medipol Bahçelievler

2017 - 2023

Prywatny İstinye Univ. Szpital w parku medycznym Gaziosmanpaşa

2015 - 2017

Szpital Szkoleniowo-Badawczy DPÜ Evliya Çelebi

2012 - 2015

Wydział Lekarski Uniwersytetu Süleymana Demirela

2008 - 2011

Szpital Państwowy w Kırıkkale

2007 - 2007

Szpital Szkolno-Badawczy Elazığ

2007 - 2008

Szpital wojskowy w Eskisehir

2005 - 2007

Szpital Państwowy Elazığ Karakoçan

2001 - 2001

Centrum Zdrowia Batmana Beşiriego İkiköprü

2001 - 2005

Wydział Lekarski Uniwersytetu Dicle, Katedra Chorób Wewnętrznych

Edukacja:

2015

Uniwersytet Süleymana Demirela Wydział Lekarski, Nefrologia

2005

Wydział Lekarski Uniwersytetu Dicle, Chorób Wewnętrznych

2000

Uniwersytet Ege, Wydział Lekarski

Międzynarodowe czasopisma recenzowane:

Tytuł: Prospektywne badanie nadzoru nad czynnikami ryzyka zakażeń krwiobiegu związanych z cewnikiem do żyły centralnej.

• Autorzy: Hoşoğlu Salih, Akalın Şerife, Kıdır Veysel, Süner Ali, Kayabaşı Hasan, Geyik Mehmet Faruk.
• Czasopismo: American Journal of Infection Control (2004), 32, 131-134.

Tytuł: Poziom białka C-reaktywnego (CRP) w surowicy a insulinooporność u nieotyłych kobiet z zespołem policystycznych jajników oraz wpływ bikalutamidu na hirsutyzm, poziom CRP i insulinooporność.

• Autorzy: Bahçeci Mithat, Tuzcu Alpaslan Kemal, Canoruç Naime, Tüzün Ahmet Yekta, Kıdır Veysel, Aslan Çetin.
• Dziennik: Badania hormonalne (2004), 62(6), 283-287.

Tytuł: Spontaniczne pęknięcie śledziony u pacjenta hemodializowanego.

• Autorzy: Aldemir Mustafa, Süner Ali, Kıdır Veysel, Balakan Ozan, Çelenk Tahir.
• Dziennik: European Journal Of General Medicine (2004), 1(3), 51-54.

Tytuł: Wpływ marskości wątroby na czynność komór serca.

• Autorzy: Usul Soyoral Yasemin, Süner Ali, Kıdır Veysel, Arıtürk Atılgan Zuhal, Balakan Ozan.
• Dziennik: European Journal Of General Medicine (2004), 1(2), 15-18.

Tytuł: Rozwój skrzepliny mnogiej przedsionków u pacjenta z poważną talasemią po splenektomii.

• Autorzy: Kıdır Veysel, Balakan Ozan, Süner Ali, İt Dede, Ayyıldız Mehmet Orhan.
• Czasopismo: Uhod-International Journal of Hematology-Oncology (2005), 15(2), 100-103.

Tytuł: Leczenie fenofibratem u dwóch osób dorosłych z zespołem Criglera-Najjara typu II.

• Autorzy: Yılmaz Şerif, Dursun Mehmet, Canoruç Fikri, Kıdır Veysel, Beştaş Remzi.
• Dziennik: Turkish Journal Of Gastroenterology (2006), 17(1), 62-65.

Tytuł: Niedokrwistość mikrocytarna hipochromiczna objawiająca się niewielką talasemią i zatruciem ołowiem.

• Autorzy: Süner Ali, Balakan Ozan, Kıdır Veysel, Kara İsmail Hamdi.
• Czasopismo: Uhod-International Journal of Hematology-Oncology (2006), 16(3), 133-136.

Tytuł: Wpływ allopurinolu na kwasicę metaboliczną i funkcje śródbłonka u pacjentów z przewlekłą chorobą nerek.

• Autorzy: Bayram Dilara, Sezer Mehmet Tuğrul, İnal Salih, Altuntaş Atila, Kıdır Veysel, Orhan Hikmet.
• Czasopismo: Nefrologia kliniczna i eksperymentalna (2014), 19(3), 443-449.

Tytuł: Wyciek dializatu otrzewnowego z pochwy u pacjentki dializowanej otrzewnowej.

• Autorzy: Kıdır Veysel, Altuntaş Atila, İnal Salih, Değirmenci Bumin, Sezer Mehmet Tuğrul.
• Dziennik: Afereza terapeutyczna i dializa (2014), 18(2), 211-212.

Tytuł: Wpływ biokompatybilnych roztworów do dializy otrzewnowej na stosunek liczby neutrofilów do limfocytów.

• Autorzy: İnal Salih, National Okyay Gülay, Ulu Memnune Sena, Kıdır Veysel, Altuntaş Atila, Ahsen Ahmet, Ünverdi Selman, Akoğlu Hadim, Yüksel Şeref, Duranay Murat, Sezer Mehmet Tuğrul.
• Dziennik: Niewydolność nerek (2014), 36(8), 1239-1243.

Tytuł: Przydatność stosunku kreatyniny do cystatyny C w surowicy w diagnostyce dysfunkcji nerek u pacjentów z cukrzycą typu 2.

• Autorzy: Kıdır Veysel, Ünverdi Selman, Ahsen Ahmet, Orhan Hikmet, Duranay Murat, İnal Salih, Sezer Mehmet Tuğrul.
• Czasopismo: Journal Of Clinical Laboratory Analysis (2015), 29(4), 294-300.

Konferencje naukowe:

Tytuł: Związek pomiędzy poziomem białka C-reaktywnego w surowicy a insulinoopornością u nieotyłych kobiet z zespołem policystycznych jajników.

• Autorzy: Bahçeci Mithat, Tuzcu Alpaslan Kemal, Canoruç Naime, Tüzün Ahmet Yekta, Kıdır Veysel, Aslan Çetin.
• Konferencja: 13. doroczne spotkanie i kongres kliniczny Amerykańskiego Stowarzyszenia Endokrynologów Klinicznych (AACE), 2004.

Tytuł: Wpływ marskości wątroby na czynność komór serca.

• Autorzy: Usul Soyoral Yasemin, Süner Ali, Kıdır Veysel, Arıtürk Atılgan Zuhal, Balakan Ozan.
• Konferencja: Europejski Kongres Kardiologiczny, 2004.

Tytuł: Rozwój skrzepliny mnogiej przedsionków u pacjenta z poważną talasemią po splenektomii.

• Autorzy: Kıdır Veysel, Balakan Ozan, Süner Ali, İt Dede, Ayyıldız Mehmet Orhan.
• Konferencja: Turecki Narodowy Kongres Hematologiczny, 2005.

Tytuł: Niedokrwistość mikrocytarna hipochromiczna objawiająca się niewielką talasemią i zatruciem ołowiem.

• Autorzy: Süner Ali, Balakan Ozan, Kıdır Veysel, Kara İsmail Hamdi.
• Konferencja: Turecki Narodowy Kongres Hematologiczny, 2006.

Tytuł: Wpływ allopurinolu na kwasicę metaboliczną i funkcje śródbłonka u pacjentów z przewlekłą chorobą nerek.

• Autorzy: Bayram Dilara, Sezer Mehmet Tuğrul, İnal Salih, Altuntaş Atila, Kıdır Veysel, Orhan Hikmet.
• Konferencja: Europejskie Towarzystwo Nefrologiczne – Kongres Europejskiego Stowarzyszenia Dializ i Przeszczepów (ERA-EDTA), 2014.

Tytuł: Wyciek dializatu otrzewnowego z pochwy u pacjentki dializowanej otrzewnowej.

• Autorzy: Kıdır Veysel, Altuntaş Atila, İnal Salih, Değirmenci Bumin, Sezer Mehmet Tuğrul.
• Konferencja: Europejskie Towarzystwo Nefrologiczne – Kongres Europejskiego Stowarzyszenia Dializ i Przeszczepów (ERA-EDTA), 2014.

Tytuł: Wpływ biokompatybilnych roztworów do dializy otrzewnowej na stosunek liczby neutrofilów do limfocytów.

• Autorzy: İnal Salih, National Okyay Gülay, Ulu Memnune Sena, Kıdır Veysel, Altuntaş Atila, Ahsen Ahmet, Ünverdi Selman, Akoğlu Hadim, Yüksel Şeref, Duranay Murat, Sezer Mehmet Tuğrul.
• Konferencja: Doroczna konferencja dotycząca dializ, 2014.

Tytuł: Przydatność stosunku kreatyniny do cystatyny C w surowicy w diagnostyce dysfunkcji nerek u pacjentów z cukrzycą typu 2.

• Autorzy: Kıdır Veysel, Ünverdi Selman, Ahsen Ahmet, Orhan Hikmet, Duranay Murat, İnal Salih, Sezer Mehmet Tuğrul.
• Konferencja: Kongres Europejskiego Stowarzyszenia Chemii Klinicznej i Medycyny Laboratoryjnej (EFLM), 2015.